5,245 家公司符合
Showing 3,151–3,200 of 5,245
| 公司 | 评级 | 股价 | 距高点 | 市盈率 | 规模 | 股息率 | 期权 | 行业 |
|---|---|---|---|---|---|---|---|---|
| A | US$20.07 | -6% | 12.31 | US$361M | 3.3% | 月度 | Banks Regional | |
| CCIICOHEN CIRCLE ACQUISITION CORP. II | 未评级 | US$10.39 | -0% | — | US$360.3M | — | — | Shell Companies |
| C- | US$2.43 | -83% | — | US$359.1M | — | 周度 | Drug Manufacturers Specialty and Generic | |
| A | US$7.91 | -40% | — | US$357.8M | — | 月度 | Software Application | |
| STLNStarling Oncology, Inc. | A | US$3.51 | -50% | — | US$357.5M | — | 月度 | Medical Care Facilities |
| D- | US$6.38 | -29% | 22.79 | US$357.1M | 3.1% | 月度 | Footwear and Accessories | |
| D- | US$18.49 | -28% | — | US$354.9M | — | — | Real Estate Services | |
| XRNChiron Real Estate Inc. | B+ | US$26.79 | -28% | 7.29 | US$354.9M | — | 月度 | Reit Healthcare Facilities |
| ARCIARCHIMEDES TECH SPAC PARTNERS III CO. | 未评级 | US$10.05 | -1% | — | US$354.4M | — | — | Shell Companies |
| F- | US$13.15 | 0% | — | US$354M | — | — | Farm Products | |
| BDCIBTC DEVELOPMENT CORP. | 未评级 | US$10.19 | -0% | — | US$353.9M | — | — | Shell Companies |
| 未评级 | US$3.65 | -67% | — | US$353.1M | — | 月度 | Biotechnology | |
| A | US$24.14 | -16% | 9.07 | US$350.9M | 0.7% | 月度 | Specialty Industrial Machinery | |
| F- | US$14.26 | -63% | — | US$350.6M | — | 月度 | Biotechnology | |
| ARTCART TECHNOLOGY ACQUISITION CORP. | 未评级 | US$10.06 | 0% | — | US$350.2M | — | — | Shell Companies |
| 未评级 | US$1.93 | -72% | — | US$350M | — | 月度 | Other Industrial Metals and Mining | |
| D | US$4.19 | -12% | — | US$349.5M | — | 月度 | Software Infrastructure | |
| D | US$21.63 | -8% | — | US$349.3M | — | — | Real Estate Services | |
| D- | US$1.59 | -83% | — | US$348.9M | — | 周度 | Electrical Equipment and Parts | |
| KARDKardigan, Inc. | 未评级 | US$13.83 | -47% | — | US$348.5M | — | — | Biotechnology |
| A | US$9.19 | -25% | 24.18 | US$348.2M | — | 月度 | Medical Devices | |
| C | US$7.12 | -14% | — | US$348.2M | 5.5% | 月度 | Security and Protection Services | |
| A+ | US$52.86 | 0% | 10.57 | US$346.9M | — | — | Banks Regional | |
| F- | US$5.85 | -52% | — | US$346.9M | — | — | Electrical Equipment and Parts | |
| 未评级 | US$4.12 | -20% | — | US$345.7M | 18.4% | 月度 | Asset Management | |
| A | US$106.32 | -5% | 11.40 | US$345.5M | 1.8% | — | Banks Regional | |
| D- | US$5.27 | -1% | — | US$345.5M | — | 月度 | Medical Devices | |
| 未评级 | US$4.30 | -30% | — | US$345.3M | — | 月度 | Biotechnology | |
| YDESYD Bio Limited | D | US$4.88 | -68% | — | US$345.1M | — | — | Biotechnology |
| D- | US$1.71 | -88% | — | US$342.7M | — | 周度 | Pollution and Treatment Controls | |
| 未评级 | US$30.74 | -37% | — | US$342.7M | — | — | — | |
| F- | US$6.63 | -36% | — | US$342.2M | — | — | Consulting Services | |
| C | US$10.67 | -36% | — | US$341.2M | — | — | Biotechnology | |
| NUAINEW ERA ENERGY & DIGITAL, INC. | F | US$3.19 | -60% | — | US$339.9M | — | 周度 | Software Infrastructure |
| D | US$43.07 | -4% | 11.33 | US$339.2M | 2.7% | — | Banks Regional | |
| 未评级 | US$31.03 | -10% | — | US$338.9M | 3.9% | 月度 | Banks Regional | |
| F- | US$2.81 | -94% | — | US$337.7M | — | 月度 | Medical Devices | |
| D | US$2.89 | -51% | — | US$337.1M | 24.9% | 月度 | Reit Mortgage | |
| B | US$32.58 | -11% | 14.22 | US$336.5M | 3.9% | — | Utilities Regulated Water | |
| A | US$21.82 | -27% | 10.34 | US$336.4M | 6.4% | — | Insurance Property and Casualty | |
| B | US$2.31 | -16% | 46.10 | US$336.3M | — | 月度 | Software Application | |
| A+ | US$28.79 | 0% | 12.04 | US$336M | — | — | Banks Regional | |
| F- | US$9.49 | -19% | — | US$335.8M | — | 月度 | Oil Gas E and P | |
| C- | US$3.60 | -30% | — | US$334.9M | — | 月度 | Broadcasting | |
| B- | US$2.17 | -42% | — | US$334.1M | — | 月度 | Biotechnology | |
| D | US$18.77 | -58% | — | US$333.6M | — | 月度 | Auto Parts | |
| F- | US$15.16 | -21% | — | US$332.8M | — | — | Reit Office | |
| D | US$22.25 | -10% | 12.43 | US$330.7M | 1.6% | — | Apparel Retail | |
| D- | US$1.65 | -75% | — | US$330.6M | — | — | Medical Devices | |
| F | US$13.32 | -33% | 19.03 | US$330.4M | 3.6% | 月度 | Information Technology Services |
筛选不是推荐。每一行都只满足了所述条件,仅此而已——InspectStocks 依据公司自己的 SEC 申报文件描述业务,不建议买入或卖出任何标的。